Decreased C-reactive protein levels in Alzheimer disease - Test2 - elhamkhani - TriplyDB

Decreased C-reactive protein levels in Alzheimer disease

Decreased C-reactive protein levels in Alzheimer disease

http://www.wikidata.org/entity/Q35482118

about

The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI The future of blood-based biomarkers for Alzheimer's disease.Disease risk factors identified through shared genetic architecture and electronic medical records Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases.A depressive endophenotype of mild cognitive impairment and Alzheimer's disease A blood-based algorithm for the detection of Alzheimer's disease Molecular neuropsychology: creation of test-specific blood biomarker algorithms.Contra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study.Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study.The link between C-reactive protein and Alzheimer's disease among Mexican Americans.Biomarkers of Alzheimer's disease among Mexican Americans.Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's disease Biomarkers of basic activities of daily living in Alzheimer's disease.Molecular markers of neuropsychological functioning and Alzheimer's disease.Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease KIF6 719Arg Carrier Status Association with Homocysteine and C-Reactive Protein in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Patients.Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection.The Hachinski ischemic scale and cognition: the influence of ethnicity.C-reactive protein and ageing.Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load.Molecular markers of amnestic mild cognitive impairment among Mexican Americans.Differences between early and late onset Alzheimer's disease.Soluble interleukin-6 receptor levels and risk of dementia: one more signpost on a long road ahead.Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.The association of high sensitivity C-reactive protein and incident Alzheimer disease in patients 60 years and older: The HUNT study, Norway.A depressive endophenotype of poorer cognition among cognitively healthy community-dwelling adults: results from the Western Australia memory study.Neuroinflammation in Alzheimer's Disease: Pleiotropic Roles for Cytokines and Neuronal Pentraxins.A Meta-Analysis of C-Reactive Protein in Patients With Alzheimer's Disease.Systemic Inflammation Is Associated With Longitudinal Changes in Cognitive Performance Among Urban Adults Decreased plasma C-reactive protein levels in 4 allele carriers IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer's disease: Systematic Review and Meta-Analysis

P2860

Q26781815-43288AC8-DA6E-4BB1-A634-B7208A88F58F Q28741766-39F7CDE3-3D22-4904-9C77-A8C5548D6807 Q34026317-94FD7479-18EF-45E6-9976-E726B109C47D Q34418291-E9CFB63B-7C45-4E94-9161-E36F06A08F1D Q34482706-394E957F-8169-4721-9AAF-5D8BFE37F3DC Q34851404-6E3A8FCB-94A3-4A79-AFAB-BD473F9C0A91 Q35203409-2F9AC133-7D13-46FC-A27C-5F3A45AF1CCE Q35456265-EFD06FDA-32F3-40D8-AC99-AFFC3EAB50F9 Q35820242-1C5D2613-B520-4FCC-914F-F73E26AB143C Q36381738-450C1CD4-8DB2-42BB-84F8-B9C790FA621E Q36716958-F67B0367-E9EB-40CE-ABC0-26B8ED98D807 Q36716970-662A2C68-2305-4E59-ADAC-91DCFBB2307E Q36780771-D57DB0B0-37E2-47F2-AE17-62B4289DA157 Q36818214-7DCBB925-DCC9-44F5-88E1-2B01ACFBF104 Q36926716-F619C764-54B1-426B-A76C-0C3DD9544015 Q37273976-D606A0D7-570D-45D1-B3C4-DB5EE6DA0B85 Q37448495-16539742-1129-4289-990E-EEA54C4290D2 Q37668003-C7F7989E-4D2E-41B1-9CC7-4E7B09FF243F Q37725833-A125F595-A468-43BA-8F4A-220257F2C220 Q39221135-02ABC468-0B4F-42D8-B8A6-122DD1F46512 Q39401091-775151AB-D306-4389-9FE2-C0101E8BDB25 Q40139851-9B9338E3-5DF0-4FE5-8932-24DB8B92A9E6 Q40457858-7B7C1F26-CA55-47D7-BF74-E59EB69AE110 Q42043147-B7C18167-08F5-4C91-90A9-E800CC2247D0 Q43244936-A145F348-870C-47EF-B21C-972CE00A9E7B Q47417067-7F2DC42C-644C-4445-A37C-AD350F1C1515 Q47550084-6F639D86-5413-40D6-9EC5-C50D98E1A29B Q48176222-5143DBCA-62E0-480A-AC12-791E577AB97C Q49808096-7DD32779-A67D-4A7D-8A13-98A93C38A9DB Q50569215-2962F5D2-03DF-4AC2-92AB-564E5D953E4F Q57816573-73002162-8160-4FB3-81D7-7FF770DFB562 Q57822080-9850FFA3-6299-4A12-830C-82E8C536E966 Q58786722-6D16AF01-2AD8-47EE-BA5B-31B5193DA603

P2860

Decreased C-reactive protein levels in Alzheimer disease

http://www.wikidata.org/entity/Q35482118

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Decreased C-reactive protein levels in Alzheimer disease

@ast

Decreased C-reactive protein levels in Alzheimer disease

@en

type

label

Decreased C-reactive protein levels in Alzheimer disease

@ast

Decreased C-reactive protein levels in Alzheimer disease

@en

prefLabel

Decreased C-reactive protein levels in Alzheimer disease

@ast

Decreased C-reactive protein levels in Alzheimer disease

@en

P1433

Q35482118-31B3FDB5-BE3F-405D-8B72-09770F95E409

P1476

Q35482118-C8C327AF-4AAD-4445-8F81-142DFA4ACDAF

P2093

Q35482118-3778B44B-A349-4EEB-A2C0-9253F9E1C073

Q35482118-5E2F7866-B878-4EAE-BAA1-D369E382E7E8

Q35482118-A12BF23F-FF2D-4896-AFB0-2F3F2F0B3E3A

Q35482118-A8103B0B-A9ED-4F5C-9971-241B6B3699B0

Q35482118-B64053C9-62B3-4334-8BE1-9FE29AF6E539

Q35482118-E790DE59-9A0F-4BA7-8D25-609D1828C0AE

P2860

Q35482118-040AAEFB-3DD7-40FF-B68D-73F4E8E6AC54

Q35482118-11F97E8A-5B41-460B-B490-F04C7F264C99

Q35482118-1393F9F0-F169-45F8-8374-89694C7C8E2C

Q35482118-18AB6070-0DD7-4D15-AEE9-56A0A3ED1901

Q35482118-19CF189A-9197-4242-85FD-69D29784B9B2

Q35482118-1A04C7D6-D9D4-43C3-8BB2-C5CD7B2D7842

Q35482118-1E1E1B71-A1C6-43AB-8DE4-8ABF89B495F6

Q35482118-211E1AFA-9316-48BD-9950-2C59C86B17F5

Q35482118-30EB2C1B-93D1-4EFB-933E-4502C08FEE83

Q35482118-347923A5-F6ED-4ACE-85B3-032D96B397B4

P304

Q35482118-32008FB3-527A-4F8D-B469-EA102689E11B

P31

Q35482118-892E5B87-034E-4D63-BE3A-25DE7795DAAD

P356

Q35482118-38F3507F-1555-4457-9BF9-2D70D7D8FF2B

P433

Q35482118-F44BE022-6C12-4FA3-8E44-4BB40E6F846F

P478

Q35482118-CC197926-202A-4D10-A177-4353DB054485

P50

Q35482118-3CEEA39A-10A8-493F-BCA1-C0A201568C09

Q35482118-DC8B1608-4ED3-466A-B967-E5A2C34EAEA6

P577

Q35482118-1738C478-DC6A-4EB7-9D0E-EF0B449E386A

P5875

Q35482118-3C15C89C-B422-4CFE-9A37-508AE6494A83

P698

Q35482118-E2F52B14-AAFE-41EA-BAD4-0C721149F8B7

P921

Q35482118-451FB002-95ED-452C-A11E-E86BAFE4F789

P932

Q35482118-F18E2A10-305B-46A3-83B6-11E80ECDE83E

P356

0891988709351832

P1433

Journal of Geriatric Psychiatry and Neurology

P1476

Decreased C-reactive protein levels in Alzheimer disease

@en

P2093

Carol B Moore

http://www.w3.org/2001/XMLSchema#string

James R Hall

http://www.w3.org/2001/XMLSchema#string

Paul Massman

http://www.w3.org/2001/XMLSchema#string

Stephen C Waring

http://www.w3.org/2001/XMLSchema#string

Teodoro Bottiglieri

http://www.w3.org/2001/XMLSchema#string

Valerie Hobson

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

Hemostatic and inflammatory markers as risk factors for coronary disease in the elderly.

P304

49-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0891988709351832

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Ramon Diaz-Arrastia

P577

2009-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40026855

http://www.w3.org/2001/XMLSchema#string

P698

19933496

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3204581

http://www.w3.org/2001/XMLSchema#string